Rheumatoid Factor Interference Kit

• Description:

  Rheumatoid Factor Interference Kit_x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_

  Catalog number:	K2010007
  Lot number:	Batch Dependent
  Expiration date:	Batch Dependent
  Package Content	Rheumatoid Factor (2 mL). Rheumatoid Factor Diluent (2 x 2 mL)
  Other names:	RF, rheumatoid arthritis factor, rheumatoid arthritis antibody,
  Keywords:	Rheumatoid Factor, RF, rheumatoid arthritis factor, rheumatoid arthritis antibody, Rheumatoid factor interference immunoassays, Rheumatoid factor Elisa interference, Rheumatoid factor assay interference, rheumatoid factor interference kits
  Shelf-life	12 months
  Storage:	-20°C

  _x000D_

  All Interference Products Brochure_x000D_

  _x000D_ _x000D_ _x000D_ References_x000D_

  _x000D_
  • Hollander, J. L. (1968). Rheumatoid Arthritis, Rheumatoid Factor, and Gamma G Globulin Fragments. Annals of Internal Medicine, 68(5), 1195.
  _x000D_
  • Pappas, D. A., and Bathon, J. M. (2009). Treatment of Rheumatoid Arthritis: Tumor Necrosis Factor Inhibitors. Rheumatoid Arthritis, 337€“349.
  _x000D_
  • Shingu, M., Ezaki, I., and Nobunaga, M. (1988). Complement-activating properties of immune complexes are suppressed by IgM rheumatoid factor and enhanced by IgG rheumatoid factor. Rheumatology International, 8(3), 95€“100.
  _x000D_
  • Vaughan, J. H. (1993). Pathogenetic concepts and origins of rheumatoid factor in rheumatoid arthritis. Arthritis and Rheumatism, 36(1), 1€“6.
  _x000D_
  • Xing Q, Fu L, Yu Z, Zhou X. Efficacy and Safety of Integrated Traditional Chinese Medicine and Western Medicine on the Treatment of Rheumatoid Arthritis: A Meta-Analysis. Evid Based Complement Alternat Med. 2020 Apr 2;2020:4348709.
  _x000D_
  • Raine C, Austin K, Giles I. Mechanisms determining the amelioration of rheumatoid arthritis in pregnancy: A systematic review. Semin Arthritis Rheum. 2020 Mar 19. pii: S0049-0172(20)30079-2.
  _x000D_
  • Toussirot E. The Interrelations between Biological and Targeted Synthetic Agents Used in Inflammatory Joint Diseases, and Obesity or Body Composition. Metabolites. 2020 Mar 13;10(3). pii: E107.
  _x000D_
  • Ishikawa Y, Terao C. The Impact of Cigarette Smoking on Risk of Rheumatoid Arthritis: A Narrative Review. Cells. 2020 Feb 19;9(2). pii: E475.
  _x000D_
  • Lin YJ, Anzaghe M, Schülke S. Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis. Cells. 2020 Apr 3;9(4). pii: E880.
  _x000D_
  • Capone A, Volpe E. Transcriptional Regulators of T Helper 17 Cell Differentiation in Health and Autoimmune Diseases. Front Immunol. 2020 Mar 12;11:348.
  _x000D_

  _x000D_  _x000D_ _x000D_ Products Related to Rheumatoid Factor Interference Kit_x000D_ _x000D_ https://moleculardepot.com/product/hama-interference-kit-for-assay-validation/_x000D_ _x000D_ https://moleculardepot.com/product/interference-test-kit-for-assay-validation/_x000D_ _x000D_ https://moleculardepot.com/product/interference-test-kit-extra-for-assay-validation/

• Short Description:

  Catalog #: K2010007_x000D_ Rheumatoid Factor Interference Kit is a ready-to-use kit to test Rheumatoid Factor (RF) interference in immunoassays. The kit includes a concentrated RF solution (human plasma containing a high level of RF, 2 mL) and the corresponding Rheumatoid Factor Diluent (plasma diluent (human plasma negative for RF, 4 mL). The kit also includes instructions and sample calculations. This product is for in vitro research use only. Custom bulk orders of this product are available upon request.

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height :

  0.5